share_log

Mateon Therapeutics Inc | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

SEC ·  May 3, 2019 05:28
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more